[1]
“Unlocking the Potential of Pyrazines: Structure–Activity Relationship Driven Studies against Mycobacterium tuberculosis”, AJP, vol. 19, no. 04, Jan. 2026, doi: 10.22377/ajp.v19i04.7057.